These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38179)

  • 1. A trial of sulfasalazine as adjunctive therapy in Crohn's disease.
    Singleton JW; Summers RW; Kern F; Becktel JM; Best WR; Hansen RN; Winship DH
    Gastroenterology; 1979 Oct; 77(4 Pt 2):887-97. PubMed ID: 38179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cooperative Crohn's Disease Study: results of drug treatment.
    Summers RW; Switz DM; Sessions JT; Becktel JM; Best WR; Kern F; Singleton JW
    Gastroenterology; 1979 Oct; 77(4 Pt 2):847-69. PubMed ID: 38176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
    Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
    Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Cooperative Crohn's Disease Study: adverse reactions to study drugs.
    Singleton JW; Law DH; Kelley ML; Mekhjian HS; Sturdevant RA
    Gastroenterology; 1979 Oct; 77(4 Pt 2):870-82. PubMed ID: 38177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine-related pancreatitis in patients with Crohn's disease.
    Sturdevant RA; Singleton JW; Deren JL; Law DH; McCleery JL
    Gastroenterology; 1979 Oct; 77(4 Pt 2):883-6. PubMed ID: 38178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)].
    Singleton JW
    Z Gastroenterol Verh; 1981 Jun; 19():38-40. PubMed ID: 6168133
    [No Abstract]   [Full Text] [Related]  

  • 8. National Cooperative Crohn's Disease Study: study design and conduct of the study.
    Winship DH; Summers RW; Singleton JW; Best WR; Becktel JM; Lenk LF; Kern F
    Gastroenterology; 1979 Oct; 77(4 Pt 2):829-42. PubMed ID: 38175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
    Rosén A; Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O
    Gastroenterology; 1982 Sep; 83(3):541-9. PubMed ID: 6124473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
    Sachar DB; Rubin KP; Gumaste V
    Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH; Hemphill D; Greenberg GR
    Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI; Present DH
    Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
    Lémann M; Mary JY; Duclos B; Veyrac M; Dupas JL; Delchier JC; Laharie D; Moreau J; Cadiot G; Picon L; Bourreille A; Sobahni I; Colombel JF;
    Gastroenterology; 2006 Apr; 130(4):1054-61. PubMed ID: 16618399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should we treat Crohn's disease?
    Sleisenger MH
    N Engl J Med; 1980 May; 302(18):1024-6. PubMed ID: 6102738
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternate-day prednisone treatment and treatment maintenance in Crohn's disease.
    Bello C; Goldstein F; Thornton JJ
    Am J Gastroenterol; 1991 Apr; 86(4):460-6. PubMed ID: 1672787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III.
    Malchow H; Steinhardt HJ; Lorenz-Meyer H; Strohm WD; Rasmussen S; Sommer H; Jarnum S; Brandes JW; Leonhardt H; Ewe K
    Scand J Gastroenterol; 1990 Mar; 25(3):235-44. PubMed ID: 1969678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.
    Valentine JF; Fedorak RN; Feagan B; Fredlund P; Schmitt R; Ni P; Humphries TJ
    Gut; 2009 Oct; 58(10):1354-62. PubMed ID: 19505878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
    Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C
    Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study.
    Omer B; Krebs S; Omer H; Noor TO
    Phytomedicine; 2007 Feb; 14(2-3):87-95. PubMed ID: 17240130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.